Welcome to our dedicated page for MOHO news (Ticker: MOHO), a resource for investors and traders seeking the latest updates and insights on MOHO stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect MOHO's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of MOHO's position in the market.
ECMOHO Limited (MOHO) reported its audited financial results for the fiscal year ended December 31, 2020. Total net revenue for Q4 2020 was US$71.9 million, with a gross margin of 25%, up from 17% YoY. Cumulative paying consumers grew to 10.9 million from 8.2 million, and the repeat purchase rate improved to 37.1%. However, full-year revenues decreased to US$304.9 million from US$329.5 million. The company reported a net loss of US$13.5 million, indicating a challenging year despite operational improvements.
ECMOHO Limited (Nasdaq: MOHO) has signed a memorandum of understanding (MoU) with the Royal Danish Consulate General to enhance the introduction of high-quality Danish products into the Chinese market. The partnership aims to support Danish companies in navigating online commerce in China through ECMOHO’s e-commerce platforms. CEO Zoe Wang emphasized leveraging big data for better consumer insights. The Consul General, Jakob Linulf, expressed optimism for increased trade opportunities with over 30 brands poised to offer healthcare-related products.
ECMOHO Limited (Nasdaq: MOHO) reported its Q3 2020 financial results with total net revenues of US$71.5 million, a 4.6% decrease from US$74.9 million in Q3 2019. The company faced an operating loss of US$4.2 million, compared to an operating income of US$2.7 million a year earlier. Net loss also increased, reaching US$4.1 million, versus a net income of US$1.9 million in Q3 2019. Despite these challenges, the company reported growth in cumulative paying consumers, reaching 10.5 million as of September 30, 2020.
ECMOHO Limited (Nasdaq: MOHO) will release its third-quarter financial results for the period ending September 30, 2020, on November 30, 2020. An earnings conference call will follow at 8:00 PM ET that same day. Participants must preregister online due to COVID-19 restrictions on operator-assisted calls. A replay of the call will be available until December 8, 2020. ECMOHO is a provider in the non-medical health and wellness market in China, connecting brand owners with consumers through a range of health-related products.
ECMOHO Limited (Nasdaq: MOHO) reported its second quarter 2020 results with total net revenues rising to US$100.5 million, a 14.9% year-on-year increase, but faced an operating loss of US$3.2 million, contrasting with an operating profit last year. The company experienced a net loss of US$4.5 million, down from a net income of US$1.4 million in Q2 2019. Advances included a rise in brands to 78 and a cumulative paying consumer base of 10.1 million as of June 30. Guidance for Q3 2020 suggests a revenue decline of 0% to 5% compared to Q3 2019.
ECMOHO Limited (Nasdaq: MOHO) will release its unaudited financial results for Q2 2020 on September 15, 2020. The company, a leader in China's non-medical health and wellness market, will host an earnings conference call at 9 PM U.S. Eastern Time on the same day. Participants must preregister online to obtain dial-in numbers. A replay will be available until September 23, 2020. ECMOHO focuses on marketing health supplements and wellness products, bridging brand owners with Chinese consumers.
ECMOHO Limited (Nasdaq: MOHO) has entered into a $30 million investment agreement with Anze Premium Health and Beauty Pte. Ltd. The commitment involves up to $15 million for equity and $15 million for zero coupon convertible notes. The payments will occur over three installments, with a total 29.7% equity acquisition in Anze expected upon completion. As the wellness market in China grows, the CEO highlights increasing demand for herbal medicine products, projected to reach over $21 billion by 2024. ECMOHO aims to leverage Anze's R&D capabilities to strengthen its product portfolio.
On July 14, 2020, Zoe Wang, CEO of ECMOHO Limited (Nasdaq: MOHO), spoke at the 2020 Health Industry West Lake Forum in Wuzhen. She emphasized the importance of strategic digitalization in the health industry, highlighting its role in enhancing market responsiveness, reducing costs, and improving user retention. Wang projected significant growth in China's health sector by 2030, driven by changing consumer behaviors due to the COVID-19 pandemic. ECMOHO aims to collaborate with partners to create a smart health ecosystem that offers remote health management for families.
ECMOHO Limited (MOHO) reported its Q1 2020 financial results, showing total net revenues of US$61.2 million, a 4.2% decline from US$63.9 million in Q1 2019. The company faced an operating loss of US$5.6 million, compared to an operating income of US$0.8 million a year prior. Net loss reached US$4.6 million, in stark contrast to net income of US$0.3 million in Q1 2019. Despite the challenges posed by the COVID-19 pandemic, consumer demand in health and wellness products is recovering, with Q2 2020 revenue expected between US$100 million and US$102 million.
On June 12, 2020, ECMOHO Limited (Nasdaq: MOHO) announced the filing of its annual report on Form 20-F for the fiscal year ending December 31, 2019, with the SEC. This report includes the Company's audited consolidated financial statements, accessible via the Company's investor relations website and the SEC's website. Shareholders and ADS holders can request a hard copy of the report free of charge. ECMOHO is a prominent provider in China's non-medical health and wellness market, linking brand owners with consumers through a range of health-focused products.
FAQ